doctor image.png
IMG_2056.jpg
DSC_0191.jpg
AN8A5784.jpg
doctor image.png

The Business of Emerging Medtech


S2N’s experienced team is focused on the commercial success of emerging medical technologies.  We provide practical, informed business guidance and market development support from product concept through early sales.  

SCROLL DOWN

The Business of Emerging Medtech


S2N’s experienced team is focused on the commercial success of emerging medical technologies.  We provide practical, informed business guidance and market development support from product concept through early sales.  

Efficient & Flexible Support:

We emulate the entrepreneurial spirit of our clients by being creative, collaborative, and action oriented. We work with clients at all stages of the product lifecycle, providing full-service strategic marketing support from the highly analytical to the tactical, leveraging a network of like-minded practitioners in regulatory, reimbursement, communications and other disciplines to meet the needs of med tech innovators.

  • Virtual marketing team – scalable and adaptive
  • Project-based support – collaborative and cost-effective

Experience in a Broad Range of Clinical Areas:

  • Vascular devices
  • Drug delivery
  • Surgical devices
  • Orthopedics
  • Neuro-psychiatry devices
  • Point-of-care diagnostics
  • Women’s health
  • Plastic surgery & aesthetics
  • Electrophysiology

Our Services

IMG_2056.jpg

Client Case Studies


SCROLL DOWN

Client Case Studies


Untitled.png

Situation

  • VC-backed orthopedic device company raising series B
  • Needed to validate market opportunity and economic value proposition

S2N Role

  • Developed market entry strategy and product positioning, incorporated into investor pitch deck
  • Created detailed payer-perspective economic model to support target product price point

Outcome: Received a term sheet from new investor and Raised $27M from new and existing investors

products-image.jpg

Situation

  • Brazilian company with a novel bone graft substitute
  • Deciding whether and how to enter the US market

S2N Role

  • Conducted primary research with target customers, competitors and channel partners to determine requirements for successful US market entry
  • Determined most attractive segments to enter given product features, price points, and channels
  • Developed market forecast model

Outcome: Changed focus of product development strategy

DSC_0191.jpg

Testimonials


S2N has worked with over 30 emerging medical devices companies who have raised more than $200M since 2011

SCROLL DOWN

Testimonials


S2N has worked with over 30 emerging medical devices companies who have raised more than $200M since 2011

CEO, Endoscopic Therapy Company

"The S2N team worked with us to focus and articulate our company strategy. Their work helped us communicate with investors and raise our $20 million series B round."

CEO, Interventional Device Company 

"S2N has satisfied a wide range of our marketing needs over the last 18 months, from branding & messaging to financial modeling and market intelligence. I appreciate their personal commitment to our small company. I enjoy working with everyone at S2N and consider them part of our team!" 

CEO, Drug Delivery Company

"S2N’s pricing analysis was the best I have seen in over 25 years of being in the business. Their presentation to the Board of Directors was professional both in content and style and well received."

AN8A5784.jpg

About Us


SCROLL DOWN

About Us


amy.png

Amy Siegel

Amy brings 20+ years of strategic marketing experience to S2N Health. Before co-founding S2N, Amy was VP of Strategic Marketing at Seventh Sense Biosystems and Aspect Medical Systems, where she guided new product development and strategic partnering efforts. Prior to her strategic marketing roles in medical device companies, Amy consulted for dozens of large and small med tech companies and investors with the firms Health Advances and Monitor Company. Amy also worked in the finance sector, structuring Asian trade finance loans for the U.S. Export-Import Bank. Amy earned her B.A. at Tufts University, received a Fulbright scholarship (Germany), and completed her M.A. at The Fletcher School of Law & Diplomacy.

Email: asiegel@s2nhealth.com
 

Tim Kofol

Tim has applied his analytical and financial skills to the medical device industry for over seven years. Before co-founding S2N with Amy Siegel, Tim worked as a strategic marketing consultant for Seventh Sense Biosystems and as a software engineer for Aspect Medical Systems. At Aspect, Tim helped the company develop new technology for neuro applications of its core EEG platform, creating novel algorithms, leading software development and guiding product planning. Tim received his B.S.E. from Princeton University with a degree in Operations Research and Financial Engineering. He earned his M.B.A. and M.S. in Information Systems at Boston University School of Management, from which he graduated with honors.

Email: tkofol@s2nhealth.com
 

erin.png

Erin Warner

Erin brings over 15 years of experience in medical device marketing and commercialization strategy. Erin has worked for Cappella Medical Devices, Aspect Medical Systems and Boston Scientific. In her most recent role with Cappella, Erin held a global marketing position where she focused on commercialization of a specialized coronary stent technology in Europe and South America. Erin also worked in strategic marketing for Aspect Medical where she led product and market development activities for new and existing technologies. Erin has worked in Sydney, Australia as a territory manager for Boston Scientific’s Endosurgery division. She received a BS in Management from the College of Commerce at DePaul University.

Email: ewarner@s2nhealth.com

Andrew Milgroom

Andrew joined S2N from an Intramural Research Training Award fellowship at the National Institutes of Health, where he researched new methods for deep tissue imaging using light microscopy. Prior to NIH, Andrew completed a Master's degree in Biomedical Engineering at the University of Colorado Anschutz Medical Campus, and a dual Biomedical Engineering and Biology undergraduate degree at Tufts University. While at Tufts, Andrew was an intern at T2 Biosystems and Pfizer, and developed an interest in the business side of healthcare and how to get new medical technologies to market.

Email: andrew.milgroom@s2nhealth.com